Invesco Ltd. Increases Holdings in Cardinal Health, Inc. (NYSE:CAH)

Invesco Ltd. lifted its holdings in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 4.6% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 3,182,514 shares of the company's stock after acquiring an additional 140,368 shares during the quarter. Invesco Ltd. owned 1.32% of Cardinal Health worth $376,396,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. Mirae Asset Global Investments Co. Ltd. boosted its position in Cardinal Health by 35.2% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 32,520 shares of the company's stock valued at $3,871,000 after acquiring an additional 8,471 shares in the last quarter. CHURCHILL MANAGEMENT Corp raised its position in Cardinal Health by 1.5% in the 4th quarter. CHURCHILL MANAGEMENT Corp now owns 240,422 shares of the company's stock worth $28,435,000 after buying an additional 3,576 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of Cardinal Health by 0.7% during the third quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company's stock valued at $633,298,000 after purchasing an additional 42,082 shares during the last quarter. Consolidated Planning Corp grew its holdings in shares of Cardinal Health by 40.0% in the fourth quarter. Consolidated Planning Corp now owns 8,926 shares of the company's stock worth $1,056,000 after acquiring an additional 2,552 shares during the period. Finally, Flputnam Investment Management Co. grew its position in Cardinal Health by 1.8% during the fourth quarter. Flputnam Investment Management Co. now owns 180,586 shares of the company's stock valued at $21,358,000 after buying an additional 3,148 shares during the period. Hedge funds and other institutional investors own 87.17% of the company's stock.

Remove Ads

Cardinal Health Stock Performance

CAH stock traded down $0.65 on Tuesday, hitting $134.13. 837,857 shares of the company's stock were exchanged, compared to its average volume of 2,177,940. The firm has a 50 day moving average price of $129.48 and a two-hundred day moving average price of $122.66. The stock has a market cap of $32.40 billion, a P/E ratio of 25.02, a price-to-earnings-growth ratio of 1.49 and a beta of 0.61. Cardinal Health, Inc. has a 12-month low of $93.17 and a 12-month high of $139.50.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings data on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. Sell-side analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be paid a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a yield of 1.51%. The ex-dividend date is Tuesday, April 1st. Cardinal Health's payout ratio is currently 37.69%.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on CAH. Bank of America lifted their price target on shares of Cardinal Health from $150.00 to $155.00 and gave the company a "buy" rating in a report on Friday. Citigroup increased their price objective on shares of Cardinal Health from $120.00 to $129.00 and gave the company a "neutral" rating in a research report on Friday, January 10th. Wells Fargo & Company increased their price target on Cardinal Health from $135.00 to $136.00 and gave the company an "equal weight" rating in a report on Tuesday, February 4th. JPMorgan Chase & Co. increased their price target on Cardinal Health from $142.00 to $145.00 and gave the stock a "neutral" rating in a report on Tuesday, February 4th. Finally, Jefferies Financial Group upgraded shares of Cardinal Health from a "hold" rating to a "buy" rating and upped their target price for the stock from $140.00 to $150.00 in a research note on Wednesday, February 5th. Four research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company's stock. According to MarketBeat.com, Cardinal Health currently has an average rating of "Moderate Buy" and a consensus target price of $140.86.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.